Drug resistance in cancer: an overview. - Wikidata - wikimedia - TriplyDB

Drug resistance in cancer: an overview.

Drug resistance in cancer: an overview.

http://www.wikidata.org/entity/Q34437369

about

The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor Hypoxia Overcome Cancer Cell Drug Resistance Using Natural Products Induction of Cancer Cell Death by Hyaluronic Acid-Mediated Uptake of Cytochrome C Microfluidic cell isolation technology for drug testing of single tumor cells and their clusters.Sodium MRI of glioma in animal models at ultrahigh magnetic fields.Effectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells in vitro Genomic analysis of drug resistant small cell lung cancer cell lines by combining mRNA and miRNA expression profiling.3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7 Ribonucleic acid (RNA) biosynthesis in human cancer.Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.Baicalein Induces Caspase-dependent Apoptosis Associated with the Generation of ROS and the Activation of AMPK in Human Lung Carcinoma A549 Cells.Inactivated Tianjin strain, a novel genotype of Sendai virus, induces apoptosis in HeLa, NCI-H446 and Hep3B cells.Elevated STAT3 Signaling-Mediated Upregulation of MMP-2/9 Confers Enhanced Invasion Ability in Multidrug-Resistant Breast Cancer Cells.ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies.Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms.Mathematical Modeling of Therapy-induced Cancer Drug Resistance: Connecting Cancer Mechanisms to Population Survival Rates Low-dose cisplatin-induced CXCR4 expression promotes proliferation of ovarian cancer stem-like cells.Thymoquinone chemosensitizes colon cancer cells through inhibition of NF-κB.Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds.Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T Cells.Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal.Photochemical activation of drugs for the treatment of therapy-resistant cancers.Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.EMT/MET at the Crossroad of Stemness, Regeneration and Oncogenesis: The Ying-Yang Equilibrium Recapitulated in Cell Spheroids.pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.The Effects of Selected Sesquiterpenes from Myrica rubra Essential Oil on the Efficacy of Doxorubicin in Sensitive and Resistant Cancer Cell Lines.Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB.Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.MicroRNAs and Cancer Drug Resistance.Managing Drug Resistance in Cancer: Role of Cancer Informatics.Reversing epigenetic mechanisms of drug resistance in solid tumors using targeted microRNA delivery.A Tetrameric Peptide Derived from Bovine Lactoferricin Exhibits Specific Cytotoxic Effects against Oral Squamous-Cell Carcinoma Cell Lines.Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.Controversy about pharmacological modulation of Nrf2 for cancer therapy

P2860

Q26741938-99FD3318-0B6A-405B-8701-CD7FF9CB2F18 Q26746952-F632C222-B358-4733-83A8-82B63D7C1F4B Q26783014-CDB32A06-80ED-43B1-8EC2-0286E6306449 Q26784161-7AC75E39-5BF9-40A3-ADC1-2A4FF983AEAC Q28834397-F71303C8-770B-4469-AE43-524F60A019C6 Q30364122-02F46CE4-CA01-4424-8FA0-248932735B44 Q30980381-6DADFEDF-B443-409B-A1A8-474653AB3F7E Q33744180-4C68AC33-34C4-456B-BD8C-92B3C6595470 Q33751052-77E7326C-0501-4196-AEE3-D350694CB74C Q33920786-23EE16F1-D153-43BD-B32F-539F924E6A6F Q35567989-02F28FB4-3AE0-418E-8150-27D7B1340203 Q35743521-007141CF-C345-4423-8FD1-F88A5D0DB75B Q35955377-A0060C0A-DA40-40E7-A0AB-556025489A7B Q36062083-23363849-1093-4E93-AA8C-B07D18F7B762 Q36247462-8A9C1AF3-7BCC-46AE-A14A-802D4EB79FE1 Q36260589-3CC13422-2CF8-402C-827C-956608BCED06 Q36260657-E011DD85-4EC3-480E-882A-33CA65FD786C Q36360728-E7DCAE28-A5DC-4F22-AB68-715D31A31CE4 Q36408417-A34D7E5B-E8CA-4FD8-8F3F-7CFB97F10E18 Q36634818-420960A6-D0C2-46F5-8CE1-8BC30297B94D Q36947111-0C59DC4C-722B-4CBB-923F-7C814C8728B6 Q37288226-1D509652-E270-4479-8873-AE1976E70539 Q37349707-4D48CEBA-7171-4876-84AB-E13E98C21A56 Q37687390-1C83965A-A97A-4E22-AE54-1311299A0772 Q37697414-D74E14E3-6914-4312-A045-26B2E41876B4 Q37722551-92ADB143-2DE3-4722-B1BA-675364C6CCE0 Q38349935-4D905BD2-25C7-4CF4-8428-62A08F3BDD05 Q38409528-2636A49F-9A38-4100-9760-8C343DD5C05F Q38543385-F45B9F21-A155-433E-AE3D-1F4A03CF533B Q38652053-A6519722-C89E-4891-B087-B7D37F1D85C0 Q38694640-09574ABE-2FD8-4776-8F2C-FA3C6ECA483C Q38699672-4D218403-FC00-4308-A5E4-3DEF6ED0B5B5 Q38719159-23024641-CAA9-4316-8A68-13F31D8C29B1 Q38721759-CADEE629-0CB7-4F89-8213-7534D4939419 Q38748118-02BD72B3-7128-4A7D-BD0A-B0841176E9DE Q38748135-00785ED0-4D39-4C1E-BA41-A4107CF4D727 Q38812898-E019F527-A564-4B22-8839-01DF751671C4 Q38816474-F899974C-4A75-4C5C-AF7A-329237A2920F Q38818023-24B0E727-7AD5-491F-84D0-73BD485ACF6F Q38835943-75C17ADF-1FBC-42B5-8688-73E9BBDFB64E

P2860

Drug resistance in cancer: an overview.

http://www.wikidata.org/entity/Q34437369

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Drug resistance in cancer: an overview.

@ast

Drug resistance in cancer: an overview.

@en

Drug resistance in cancer: an overview.

@nl

type

label

Drug resistance in cancer: an overview.

@ast

Drug resistance in cancer: an overview.

@en

Drug resistance in cancer: an overview.

@nl

prefLabel

Drug resistance in cancer: an overview.

@ast

Drug resistance in cancer: an overview.

@en

Drug resistance in cancer: an overview.

@nl

P1433

Q34437369-CC3626A4-1895-4854-872E-F861A37DDE2D

P1476

Q34437369-02C45EDB-CCB9-473D-A87B-4168CB037A5C

P2093

Q34437369-40916326-D0C8-4772-8D77-2312ED66E2BF

Q34437369-67A8DB3A-7F45-425F-9DDF-CDA02311E927

Q34437369-BE98839C-C310-4C1B-985F-36704E61AEEB

Q34437369-E05BC64B-5181-4841-949A-CA94833EFC80

Q34437369-ED05FE55-8B42-49AF-AA4F-93E2CEB3A63F

P2860

Q34437369-027B94DB-CBAD-416E-8E6F-B074B2389882

Q34437369-03B99406-194C-4DC9-ACA3-0BA02EF7DF99

Q34437369-08B76F70-5394-4016-B1A6-973C77B68E93

Q34437369-0A240AFB-2A5D-497F-87A7-ED3193F49290

Q34437369-0B5653CA-E056-4446-B6F7-87B5B7793271

Q34437369-0BC0F08B-38B2-461A-B34A-662519D0BADC

Q34437369-0FAB59B3-E2E7-4868-BD2E-392D8D3B482A

Q34437369-1634D46B-6375-47F4-98AB-2C9D7AF0716B

Q34437369-16A17382-CF71-44C0-A7BA-79E7F5E352BD

Q34437369-1732D020-1913-485F-BA76-C1EC40558294

P304

Q34437369-0A44B7A6-C1AD-40F9-BCF7-598ECE16440F

P31

Q34437369-089F226C-D07F-403E-A6B4-2D4E6C13EFA8

Q34437369-eaedab6e-5afd-46ea-ab42-366989f92805

P356

Q34437369-DF6F085E-37E0-4725-9348-245FD9358248

P433

Q34437369-0817E072-010B-49C8-9298-73C90073A6D7

P478

Q34437369-E33535BA-3A33-40F8-83D1-A8E724EA8E96

P50

Q34437369-5D1AD3D3-F267-47E3-ADA7-8E7F623872E6

Q34437369-7872BAB1-73BE-41C6-82F1-2C6B51D5DA09

P577

Q34437369-F5853167-FE3C-43D2-8EB8-D87591B7F196

P5875

Q34437369-54F0C877-151F-45E9-9D6F-26DD267A39EA

P698

Q34437369-40D0668F-04A8-4BBB-B13C-6F9A617A8D76

P932

Q34437369-F0BB0785-2EAA-4735-8903-F73984901370

P356

P1433

P1476

Drug resistance in cancer: an overview

@en

P2093

Karolina Lapinska

http://www.w3.org/2001/XMLSchema#string

Mckenna Longacre

http://www.w3.org/2001/XMLSchema#string

Nicole Snyder

http://www.w3.org/2001/XMLSchema#string

Sarah Heerboth

http://www.w3.org/2001/XMLSchema#string

Shannon Byler

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1

Multidrug resistance in cancer: role of ATP-dependent transporters

Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17

A perspective on cancer cell metastasis

P304

1769-1792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS6031769

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Genevieve Housman

P577

2014-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265419971

http://www.w3.org/2001/XMLSchema#string

P698

25198391

http://www.w3.org/2001/XMLSchema#string

P932

4190567

http://www.w3.org/2001/XMLSchema#string